DermBiont, Inc.

Biotechnology company · Boston, Massachusetts, United States

DermBiont, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $33 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

DermBiont at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2016

SEC CIK1779253

What does DermBiont do?

Private fundraising reported to the SEC

12 Form D notices; the most recent reported $32.7 million sold (2024).

Frequently asked questions about DermBiont

Where is DermBiont headquartered?

DermBiont, Inc. is headquartered in Boston, Massachusetts, United States.

What does DermBiont do?

DermBiont, Inc. is a biotechnology company.

When was DermBiont founded?

The earliest incorporation on record for DermBiont, Inc. is in 2016, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences